Antihistamines in the treatment of bronchial asthma. Present knowledge and future perspectives

Pulmonary Pharmacology and Therapeutics

Volumn 14, Issue 4, 2001, Pages 267-276

  Mincarini, Marcello ^a   Pasquali, Mercedes ^a   Cosentino, Cristina ^a   Fumagalli, Federica ^a   Scordamaglia, Antonio ^a   Quaglia, Roberto ^a   Canonica, Giorgio Walter ^a   Passalacqua, Giovanni ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACRIVASTINE; ALIPHATIC AMINE; ANTIHISTAMINIC AGENT; ASTEMIZOLE; AZATADINE; AZELASTINE; CAREBASTINE; CETIRIZINE; CLEMASTINE; CYCLIZINE; CYPROHEPTADINE; DESLORATADINE; DIPHENHYDRAMINE; DOXYCYCLINE; EBASTINE; FEXOFENADINE; HISTAMINE; HISTAMINE DERIVATIVE; HYDROXYZINE; LEVOCABASTINE; LORATADINE; MEPYRAMINE; MEQUITAZINE; MIZOLASTINE; NORASTEMIZOLE; PROMETHAZINE; TERFENADINE; TRIPELENNAMINE; TRIPROLIDINE; UNINDEXED DRUG;

ASTHMA; BLOOD VESSEL PERMEABILITY; BRONCHUS MUSCLE; BRONCHUS OBSTRUCTION; CLINICAL TRIAL; HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SMOOTH MUSCLE CONTRACTION;

EID: 0034929651     PISSN: 10945539     EISSN: None     Source Type: Journal    
DOI: 10.1006/pupt.2001.0292     Document Type: Review

References (113)

1. Antihistamines in the treatment of asthma
2. The use of anti-HI drugs in mild asthma
3. Antihistamines in the treatment of asthma
4. Spirometric evaluation of Benadryl in asthma
5. Antihistamines in bronchial asthma
6. The spectrum of antihistamines adversely affecting pulmonary function in asthmatic children
7. The use of antihistamines in patients with asthma
8. Practice parameters for the diagnosis and treatment of asthma
9. Antihistamines in asthma
10. Histamine and asthma: An appraisal based on specific H1-receptor antagonism
11. Antihistamines and allergic asthma
12. Histamine and asthma
13. The contribution of histamine to bronchoconstriction produced by inhaled allergen and adenosine 5′-monophosohate in asthma
14. Allergen-induced increase in non-allergic bronchial reactivity
15. Mediators and inflammatory cells in allergic disease
16. Bronchoalveolar lavage of allergic asthmatic patients following allergen provocation
17. Immunologic studies in allergen-induced late phase asthmatic reactions
18. Elevated bronchoalveolar lavage fluid histamine levels in allergic asthmatic are associated with increased airway obstruction
19. The clinical safety of H1-receptor antagonists
20. Adhesion molecules of allergic inflammation: Recent insights into their functional roles
21. Early detection of specific IgE antibody against house dust mite in children at risk of allergic disease
22. The comparative actions and adverse effect profile of single doses of H1-receptor antihistamines in the airways and skin of subjects with asthma
23. Cetirizine in patients with seasonal allergic rhinitis and concomitant asthma: Prospective, randomized, placebo-controlled trial
24. Double-blind multicenter study of cetirizine in grass-pollen-induced asthma
25. Cetirizine in pollen-associated asthma
26. Prophylactic treatment of grass pollen-induced asyhma with cetirizine
27. Effect of H1 receptor blockade on the early and late response to cutaneous allergen challenge
28. Comparison of the brochodilatory effects of cetirizine, albuterol, and both together versus placebo in patients with mild-to-moderate asthma
29. Is there a place for antihistamines in the treatment of perennial asthma?
30. Prospective effect of cetirizine in patients suffering from pollen asthma
31. Cetirizine: A new nonsedating antihistamine
32. The effect of 2 weeks treatment with cetirizine on bronchial reactivity to methacholine in asthma
33. Effect of cetirizine on histamine-induced bronchoconstriction and bronchoalveolar cell
34. Effect of a non sedative antihistaminic (loratadine) in moderate asthma
35. Lack of effect of loratadine on moderate to severe asthma
36. Comparison of the effect of loratadine on the airway and skin responses to histamine methacholine and allergen in subjects with asthma
37. The effect of loratadine on skin and bronchial reactivity and histamine liberation from basophils in patients with atopic asthma and allergic rhinitis
38. Effect of loratadine selective antagonist of histamine (H1) receptor on allergen induced bronchoconstriction in atopic asthmatics
39. Allergic bronchial asthma treated with Loratadine
40. Efficacy and safety of loratadine plus pseudoephedrine in patients with seasonal allergic rhinitis and mild asthma
41. Astemizole in asthmatic patients. Effect on histamine and allergen challenge
42. Duration of the effect of astemizole on histamine-inhalation test
43. The effect of astemizole on bronchial hyperresponsiveness and exercise-induced Asthma in children
44. Single-dose effect of astemizole on bronchoconstriction induced by histamine in asthmatic subjects
45. Effect of astemizole on allergic asthma
46. The effect of astemizole on exercise-induced asthma
47. Arrhythmogenic mechanisms of nonsedating antihistamines
48. Mechanism of the cardioitoxic actions of terfenadine
49. H1-receptor antagonist comparitive tolerability and safety
50. Effect of azelastine on bronchoconstriction induced by histamine and leukotriene C4 in patients with extrinsic asthma
51. The inhibitory action of azelastine hydrochloride on the early and late bronchoconstrictor responses to inhale in atopic asthma
52. The inhibitory effect of azelastine and ketotifen on histamine-induced bronchoconstriction in asthmatic patients
53. A study of the clinical efficacy of azelastine in patients with extrinsic asthma, and its effect on airway responsiveness
54. The effect of single and multiple dose therapy with azelastine on the immediate asthmatic response to allergen provocation testing
55. The effect of azelastine on exercise-induced asthma
56. Azelastine (AZEL) in the treatment of asthma
57. A double blind controlled study of the effect of the specific H1 histamine receptor antagonist terfenadine in chronic severe asthma
58. Lack of effect of four weeks of oral H1 antagonist on bronchial responsiveness
59. Treatment of bronchial asthma with terfenadine; a randomized controlled trial
60. Terfenadine, a potent histamine H1 receptor antagonist in the treatment of grass pollen sensitive asthma
61. Long-term, placebo-controlled trial of ketotifen in the management of preschool children with asthma
62. Efficacy and safety of ketotifen in young children with asthma
63. A Canadian multicenter study with Zaditen (ketotifen) in the treatment of bronchial asthma in children aged 5 to 17 years
64. Ketotifen in the treatment of infants and young children with wheezy bronchitis and bronchial asthma
65. Prevention of asthma by ketotifen in infants with atopic dermatitis
66. A double blind study of the effectiveness of Ketotifen in preventing the development of asthma in atopic dermatitis patients
67. A steroid-sparing effect of ketotifen in steroid dependent asthmatics
68. Effect of ketotifen on childhood asthma: A double blind study
69. Long-term modification on histamine-induced bronchoconstriction by disodium cromoglycate and ketotifen versus placebo
70. Acute effect of ketotifen on the dose-response curve of histamine and methacholine in asthma
71. The effect of ketotifen on bronchial hyperreactivity in childhood asthma
72. Reduction in the oral doses of theophylline in asthmatic children during concomitant treatment with ketotifen
73. Dose-response relationship of the H1 histamine antagonist ebastine against histamine and methacholine induced bronchoconstriction in patients with asthma
74. Allergic Rhinobronchitis: The allergic rhinitis-asthma link
75. Long term risk factors for developing asthma and allergic rhinitis: A 23 year follow up study of college students
76. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis and atopic eczema
77. Epidemiological evidence of the occurrence of rhinitis and sinusitis in asthma
78. The impact of allergic rhinitis on bronchial asthma
79. Mechanism of nose-lung interaction
80. Treatment of allergic rhinitis with intranasal corticosteroids in patients with mild asthma: Effect on lower airway responsiveness
81. Once daily intranasal fluticasone propionate (200 micrograms) reduces nasal symptoms and inflammation but also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitis
82. Non H1 receptor effects of antihistamines
83. Inhibitory activity of Loratadine and descarboethoxyloratadine on expression of ICAM-1 and HLA-DR by nasal epithelial cells
84. Terfenadine and fexofenadine reduce in vitro ICAM-1 expression on human continuous cell lines
85. Inhibitory effect of cetirizine on the bronchial eosinophilic recruitment induced by allergen inhalation challenge in allergic patients with asthma
86. Cetirizine inhibits the in vitro and ex vivo chemotactic response of T lymphocytes and monocytes
87. Pharmacologic modulation by cetirizine of some adhesion molecules expression in psoriatic skin lesions
88. Quantitative flow cytometric analysis of the effects of cetirizine on the expression of ICAM-1 on primari cultured nasal cells
89. Effect of Oxatomide on T-cell activation and the production of interferon-gamma in mite sensitive asthma
90. Oxatomide inhibitis synthesis and release of platelet-activating factor in human neutrophils
91. Ketotifen: Current views on its mechanism of action and their therapeutic implications
92. Antagonism of histamine and leukotrienes by azelastine in guinea pig ileum
93. Effect of azelastine on the release and action on leukotriene C4 and D4
94. Modulation of in vitro anaphylaxis of guinea-pig isolated tracheal segments by azelastine, inhibitors of arachidonic acid metabolism and selected antiallergic drugs
95. Inhibition of leukotriene (SRS-A)-mediated acute lung anaphylaxis by azelastine in guinea pigs
96. Cetirizine reduces inflammatory cell recruitment and ICAM-1 (or CD54) expression on conjunctival epithelium in both early- and late-phase reaction after allergen-specific challenge
97. Cetirizine reduces conjunctival nonspecific hyperreactivity in children with mite allergy
98. Terfenadine exerts antiallergic activity reducing ICAM1 expression on nasal epithelial cell in patients with pollen allergy
99. Loratadine treatment of rhinitis due to pollen allergy reduces epithelial ICAM-I expression
100. Seasonal rhinitis and azelastine: Long or short term treatment?
101. The effect of ketotifen on the inflammation of bronchial mucosa in atopic asthmatics
102. A comparative study of the effects of ketotifen, disodium cromoglycate, and beclomethasone dipropionate on bronchial mucosa and asthma symptoms in patients with atopic asthma
103. Minimal persistent inflammation is present at mucosal level in patients with asymptomatic rhinitis and mite allergy
104. The major human rhinovirus receptor is ICAM-1
105. The relationship between upper respiratory infections and hospital admissions for asthma: A time-trend analysis
106. Continuous antihistamine treatment controls allergic inflammation and reduces respiratory morbidity in children with mite allergy
107. Longterm cetirizine treatment reduces allergic symptoms and supplemental medications use in children with mite allergy
108. Ketotifen for asthma in children aged 5 to 15 years: A randomized placebo controlled study
109. Allergic factors associated with the development of asthma and the influence of cetirizine in a double blind randomized placebo controlled trial
110. Consensus on the treatment of allergic rhinitis
111. United airways disease: Therapeutic aspects
112. Is antihistamine (H1 receptor antagonist) therapy useful in asthma?